Kunitake Hirashima - Concepedia

Author

Kunitake Hirashima

Saitama Medical University

Also Known As

K Hirashima, KUNITAKE HIRASHIMA, Kunitake HIRASHIMA, Kunitake Hirashima

Publications

935

Citations

H-Index

Concepts

All Affiliations

Saitama Medical University Kyoto University The University of Tokyo Tokyo University of Science Tokyo Medical and Dental University

About

Kunitake Hirashima is an author at Saitama Medical University specializing in medicine, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	423
2	Health Sciences	7	7	212
3	Public Health	1	1	73
4	Social Sciences	1	1	23
5	Anatomy	1	1	23

Kunitake Hirashima

Publications

820

Citations

H-Index

Page 1

	Year	Citations
Chromosomal aberrations observed in 52 mouse myeloid leukemias. Isamu Hayata, Masatoshi Seki, Kazuko Yoshida, PubMed CytogeneticsMixed-phenotype Acute LeukemiaGeneticsPathologyEpigenetics	1983	97
A phase II trial of recombinant human granulocyte colony‐stimulating factor in the myelodysplastic syndromes Yataro Yoshida, Kunitake Hirashima, Shigetaka Asano, British Journal of Haematology	1991	94
Fusion ofTEL/ETV6 to a novelACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13) Fumiharu Yagasaki, Itsuro Jinnai, Satoru Yoshida, Genes Chromosomes and Cancer	1999	91
Experimental Studies on Erythropoietin. II. The Relationship between Juxtaglomerular Cells and Erythropoietin Kunitake Hirashima, Fumimaro Takaku Blood	1962	75
Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome Chisato Nagata, Hiroyuki Shimizu, Kunitake Hirashima, Leukemia Research Occupational ToxicologyOrganic SolventsEnvironmental HealthForensic ToxicologyChemical Hazard	1999	73
Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony ‐ stimulating factor: a multicenter randomized controlled study Masami Bessho, Kunitake Hirashima, Shigetaka Asano, European Journal Of Haematology	1997	43
Partial Deletion of Chromosome #2 in Myelocytic Leukemias of Irradiated C3H/He and RFM Mice2 Isamu Hayata, Takaaki Ishihara, Kunitake Hirashima, JNCI Journal of the National Cancer Institute CytogeneticsGeneticsPathologyMyeloid NeoplasiaHematological Malignancy	1979	41
Dose-Finding, Double-Blind, Clinical Trial of Recombinant Human Erythropoietin (Chugai) in Japanese Patients with End-Stage Renal Disease Masashi Suzuki, Yoshihei Hirasawa, Kunitake Hirashima, Contributions to nephrology HemodialysisUrologyRenal FunctionKidney TransplantKidney Failure	2015	29
TRILINEAGE RECOVERY BY COMBINATION THERAPY WITH RECOMBINANT HUMAN GRANULOCYTE COLONY‐STIMULATING FACTOR (rhG‐CSE) AND RRYTHROPOIETIN (rhEpo) IN SEVERE APLASTIC ANAEMIA Masami Bessho, Akira Toyoda, Yoshihiro Itoh, British Journal of Haematology Bone Marrow FailureHematologyImmunologyMedicineAplastic Anemia	1992	26
Effects of Interleukin‐6 and Granulocyte Colony‐stimulating Factor on the Proliferation of Leukemic Blast Progenitors from Acute Myeloblastic Leukemia Patients Toshiya Suzuki, Tomohiro Morio, Shuji Tohda, Japanese Journal of Cancer Research Hematological MalignancyImmune Cell DevelopmentGranulocyte Colony‐stimulating FactorMixed-phenotype Acute LeukemiaImmunology	1990	25

Page 1